Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study

JOURNAL ARTICLE published 5 March 2020 in Blood

Authors: David J. Straus | Monika Długosz-Danecka | Sergey Alekseev | Árpád Illés | Marco Picardi | Ewa Lech-Maranda | Tatyana Feldman | Piotr Smolewski | Kerry J. Savage | Nancy L. Bartlett | Jan Walewski | Radhakrishnan Ramchandren | Pier Luigi Zinzani | Martin Hutchings | Joseph M. Connors | John Radford | Javier Munoz | Won Seog Kim | Ranjana Advani | Stephen M. Ansell | Anas Younes | Harry Miao | Rachael Liu | Keenan Fenton | Andres Forero-Torres | Andrea Gallamini